Journal article

Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015

Abstract:: Background The scale-up of tobacco control, especially after the adoption of the Framework Convention for Tobacco Control, is a major public health success story. Nonetheless, smoking remains a leading risk for early death and disability worldwide, and therefore continues to require sustained political commitment. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) offers a robust platform through which global, regional, and national progress toward achievi... Expand abstract
Collapse abstract

Publication status:: Published

Peer review status:: Peer reviewed

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

of Disease 2015 Tobacco Collaborators, G. B., Ali, R., & Hay, S. (2017). Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015. Lancet, 389(10082), 1885–1906.

MLA Style

of Disease 2015 Tobacco Collaborators, Global Burden, et al. “Smoking Prevalence and Attributable Disease Burden in 195 Countries and Territories, 1990–2015: a Systematic Analysis from the Global Burden of Disease Study 2015.” Lancet, vol. 389, no. 10082, Elsevier, 2017, pp. 1885–906.

Chicago Style

Disease 2015 Tobacco Collaborators, Global Burden of, R Ali, and S Hay. 2017. “Smoking Prevalence and Attributable Disease Burden in 195 Countries and Territories, 1990–2015: a Systematic Analysis from the Global Burden of Disease Study 2015.” Lancet 389 (10082): 1885–1906.
Share
Print

Access Document

Files:: Global Burden of Disease 2015 Tobacco Collaborators (2017) Lan...

(Preview, Version of record, pdf, 19.7MB, Terms of use)

mmc1.pdf

(Preview, Version of record, pdf, 24.0MB, Terms of use)

Publisher copy:: 10.1016/S0140-6736(17)30819-X

Authors

+ Global Burden of Disease 2015 Tobacco Collaborators More by this author

Role:: Author

+ Ali, R More by this author

Institution:: University of Oxford
Division:: MSD
Department:: NDM
Sub department:: NDM Experimental Medicine
Role:: Author

+ Hay, S More by this author

Institution:: University of Oxford
Division:: MSD
Department:: NDM
Sub department:: Human Genetics Wt Centre
Role:: Author

+ Bloomberg Philanthropies More from this funder

+ Bill and Melinda Gates Foundation More from this funder

Publisher:: Elsevier
Journal:: Lancet More from this journal
Volume:: 389
Issue:: 10082
Pages:: 1885–1906
Publication date:: 2017-04-05
Acceptance date:: 2017-01-05
DOI:: 10.1016/S0140-6736(17)30819-X
ISSN:: 0140-6736

Pubs id:: pubs:688939
UUID:: uuid:e9a024ee-7064-4b9f-9bb7-d339bf965129
Local pid:: pubs:688939
Source identifiers:: 688939
Deposit date:: 2017-04-10

Terms of use

Copyright holder:: GBD 2015 Tobacco Collaborator
Copyright date:: 2017
Notes:: Copyright © The Authors. Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.

Licence:: CC Attribution (CC BY)

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP